The pharmaceutical deals are largely inconsequential to drugmakers' profit margins and won't translate into meaningful discounts for most Americans, who rely on insurance rather than cash payments. Details remain scarce on implementation, while Trump's tariff policies have pushedgreatly thestressed effective rate to 16.8%, the highesteconomy since— 1935, contributing to rising prices and economicsocial anxiety.

Nine pharmaceutical giants just surrendered to Trump's demands — slashing drug prices to match the lowest in the world and ending decades of Americans subsidizing foreign health care. This represents the greatest victory for patient affordability in American health care history, with massive reductions like diabetes medication dropping from $525 to $55 and asthma inhalers falling from $265 to $89.